Alyeska Investment Group, L.P. C4 Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

  • $16.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$5.06 - $26.46 $664,125 - $3.47 Million
-131,250 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$19.99 - $33.23 $124,937 - $207,687
6,250 Added 5.0%
131,250 $3.18 Million
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $4.49 Million - $6.31 Million
125,000 New
125,000 $5.59 Million

Others Institutions Holding CCCC

# of Institutions
119
Shares Held
53.8M
Call Options Held
331K
Put Options Held
145K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $288M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email